| First Author | Cheng SL | Year | 2009 |
| Journal | Respir Res | Volume | 10 |
| Pages | 115 | PubMed ID | 19930612 |
| Mgi Jnum | J:265418 | Mgi Id | MGI:6200870 |
| Doi | 10.1186/1465-9921-10-115 | Citation | Cheng SL, et al. (2009) Prevention of elastase-induced emphysema in placenta growth factor knock-out mice. Respir Res 10:115 |
| abstractText | BACKGROUND: Although both animal and human studies suggested the association between placenta growth factor (PlGF) and chronic obstructive pulmonary disease (COPD), especially lung emphysema, the role of PlGF in the pathogenesis of emphysema remains to be clarified. This study hypothesizes that blocking PlGF prevents the development of emphysema. METHODS: Pulmonary emphysema was induced in PlGF knock-out (KO) and wild type (WT) mice by intra-tracheal instillation of porcine pancreatic elastase (PPE). A group of KO mice was then treated with exogenous PlGF and WT mice with neutralizing anti-VEGFR1 antibody. Tumor necrosis factor alpha (TNF-alpha), matrix metalloproteinase-9 (MMP-9), and VEGF were quantified. Apoptosis measurement and immunohistochemical staining for VEGF R1 and R2 were performed in emphysematous lung tissues. RESULTS: After 4 weeks of PPE instillation, lung airspaces enlarged more significantly in WT than in KO mice. The levels of TNF-alpha and MMP-9, but not VEGF, increased in the lungs of WT compared with those of KO mice. There was also increased in apoptosis of alveolar septal cells in WT mice. Instillation of exogenous PlGF in KO mice restored the emphysematous changes. The expression of both VEGF R1 and R2 decreased in the emphysematous lungs. CONCLUSION: In this animal model, pulmonary emphysema is prevented by depleting PlGF. When exogenous PlGF is administered to PlGF KO mice, emphysema re-develops, implying that PlGF contributes to the pathogenesis of emphysema. |
